Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23709)

• Formulation Name: Diazoxide 1.5g/30ml suspension
• Company: Par Pharmaceutical

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Diazoxide	(DML1538)	Congenital hyperinsulinism	5A4Y	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Allura red AC dye	(E00338)	33258	Colorant
Carboxymethylcellulose sodium	(E00621)	Not Available	Adsorbent; Binding agent; Disintegrant; Emulsifying agent; Suspending agent; Viscosity-controlling agent
Ethanol	(E00023)	702	Antimicrobial preservative; Penetration agent; Solvent
Hydrochloric acid	(E00015)	313	Acidulant
Magnesium aluminum silicate	(E00462)	3084116	Adsorbent; Binding agent; Disintegrant; Suspending agent; Viscosity-controlling agent
methylparaben	(E00149)	7456	Antimicrobial preservative
Poloxamer 188	(E00645)	Not Available	Emulsifying agent; Solubilizing agent; Surfactant
Propylene glycol	(E00040)	1030	Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Propylparaben sodium	(E00567)	23679044	Antimicrobial preservative
Sodium benzoate	(E00432)	517055	Antimicrobial preservative; lubricant
Sorbitan tristearate	(E00516)	17800859	Dispersing agent; Emulsifying agent; Solubilizing agent; Surfactant; Suspending agent; Vaccine adjuvant
Sunset yellow FCF	(E00255)	17730	Colorant
Water	(E00035)	962	Solvent